Goldman Sachs’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.52M | Sell |
134,398
-205,538
| -60% | -$2.32M | ﹤0.01% | 3588 |
|
2025
Q1 | $3.92M | Buy |
339,936
+12,263
| +4% | +$142K | ﹤0.01% | 2918 |
|
2024
Q4 | $2.78M | Buy |
327,673
+193,632
| +144% | +$1.64M | ﹤0.01% | 3276 |
|
2024
Q3 | $1.55M | Sell |
134,041
-78,847
| -37% | -$913K | ﹤0.01% | 3533 |
|
2024
Q2 | $2.51M | Buy |
212,888
+153,057
| +256% | +$1.8M | ﹤0.01% | 3058 |
|
2024
Q1 | $710K | Sell |
59,831
-27,268
| -31% | -$323K | ﹤0.01% | 3810 |
|
2023
Q4 | $1.07M | Sell |
87,099
-121,713
| -58% | -$1.49M | ﹤0.01% | 3584 |
|
2023
Q3 | $2.01M | Sell |
208,812
-84,499
| -29% | -$814K | ﹤0.01% | 3096 |
|
2023
Q2 | $2.64M | Buy |
293,311
+17,827
| +6% | +$160K | ﹤0.01% | 3024 |
|
2023
Q1 | $2.17M | Sell |
275,484
-70,221
| -20% | -$552K | ﹤0.01% | 3156 |
|
2022
Q4 | $2.34M | Buy |
345,705
+7,525
| +2% | +$50.9K | ﹤0.01% | 3177 |
|
2022
Q3 | $4.91M | Buy |
338,180
+36,905
| +12% | +$535K | ﹤0.01% | 2655 |
|
2022
Q2 | $2.97M | Buy |
301,275
+134,570
| +81% | +$1.32M | ﹤0.01% | 3119 |
|
2022
Q1 | $2.46M | Buy |
166,705
+67,274
| +68% | +$992K | ﹤0.01% | 3413 |
|
2021
Q4 | $1.32M | Buy |
99,431
+30,136
| +43% | +$399K | ﹤0.01% | 3818 |
|
2021
Q3 | $1.21M | Buy |
69,295
+37,685
| +119% | +$658K | ﹤0.01% | 3846 |
|
2021
Q2 | $757K | Sell |
31,610
-22,989
| -42% | -$551K | ﹤0.01% | 4194 |
|
2021
Q1 | $1.4M | Buy |
54,599
+44,029
| +417% | +$1.13M | ﹤0.01% | 3672 |
|
2020
Q4 | $201K | Buy |
+10,570
| New | +$201K | ﹤0.01% | 4269 |
|
2020
Q3 | – | Sell |
-36,781
| Closed | -$445K | – | 4497 |
|
2020
Q2 | $445K | Buy |
+36,781
| New | +$445K | ﹤0.01% | 3653 |
|
2020
Q1 | – | Sell |
-20,213
| Closed | -$360K | – | 4485 |
|
2019
Q4 | $360K | Sell |
20,213
-26,881
| -57% | -$479K | ﹤0.01% | 3796 |
|
2019
Q3 | $546K | Buy |
47,094
+26,181
| +125% | +$304K | ﹤0.01% | 3559 |
|
2019
Q2 | $463K | Sell |
20,913
-16,877
| -45% | -$374K | ﹤0.01% | 3559 |
|
2019
Q1 | $1.08M | Buy |
+37,790
| New | +$1.08M | ﹤0.01% | 3225 |
|
2018
Q1 | – | Sell |
-15,528
| Closed | -$151K | – | 4264 |
|
2017
Q4 | $151K | Buy |
+15,528
| New | +$151K | ﹤0.01% | 3883 |
|
2016
Q4 | – | Sell |
-6,820
| Closed | -$44K | – | 4502 |
|
2016
Q3 | $44K | Sell |
6,820
-5
| -0.1% | -$32 | ﹤0.01% | 4331 |
|
2016
Q2 | $63K | Sell |
6,825
-34,994
| -84% | -$323K | ﹤0.01% | 4227 |
|
2016
Q1 | $377K | Buy |
41,819
+35,332
| +545% | +$319K | ﹤0.01% | 3397 |
|
2015
Q4 | $329K | Sell |
6,487
-3,490
| -35% | -$177K | ﹤0.01% | 3466 |
|
2015
Q3 | $499K | Sell |
9,977
-2,095
| -17% | -$105K | ﹤0.01% | 3305 |
|
2015
Q2 | $1.21M | Buy |
+12,072
| New | +$1.21M | ﹤0.01% | 2855 |
|